Actions Panel

Biologics Summit Japan 2022

Don't miss out on Biologics Summit Japan 2022.

When and where

Date and time


Basel, Switzerland Basel 1010 Basel Switzerland

Map and directions

How to get there

Refund Policy

No Refunds

About this event

  • 1 day 10 hours
  • Mobile eTicket

Home to the second-largest pharmaceutical market in the world, Japan has poised itself as one of the most lucrative biotech hubs in Asia and worldwide. Over recent years, the Japanese biologics market has opened its doors to both foreign companies entering the Japanese market and companies investing abroad. Japan’s biopharma sector has had a keen eye on alliance opportunities in markets beyond its borders and although the nature of its sector is a cautious one, its move towards transparency and international collaboration provides bountiful opportunities that both the domestic and international players stand to benefit from.

The key drivers driving the growth of the biologics industry in Japan are the formation of numerous bio-clusters that house world-class universities with cutting-edge technologies and know-how, excellence in the implementation of automation technology, huge amounts of financial support for orphan drugs, tax breaks, and subsidies for new entrants in the market, the government’s push for the creation of technologies and services, and development of the supporting infrastructure. Factors hindering the growth of the biopharmaceutical industry mainly are from the bioprocessing side including high manufacturing complexities expensive purification processes and other challenges across the bioprocessing value chain. Meanwhile trials and roll outs for COVID vaccines and antivirals will position Japan at the forefront of crucial life-saving initiatives.